Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
about
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenTreatment of osteoporosis: current and future.A practical guide to preventing osteoporosis.The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal womenPrevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
P2860
Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Coherence therapy does not pre ...... preliminary comparative study.
@ast
Coherence therapy does not pre ...... preliminary comparative study.
@en
type
label
Coherence therapy does not pre ...... preliminary comparative study.
@ast
Coherence therapy does not pre ...... preliminary comparative study.
@en
prefLabel
Coherence therapy does not pre ...... preliminary comparative study.
@ast
Coherence therapy does not pre ...... preliminary comparative study.
@en
P2093
P356
P1476
Coherence therapy does not pre ...... preliminary comparative study.
@en
P2093
P304
P356
10.1210/JCEM-66-4-747
P407
P577
1988-04-01T00:00:00Z